BOSTON--(BUSINESS WIRE)--Oscar L. Bronsther, M.D., CEO of MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on developing and commercializing epigenetic-based diagnostic tests for early and reliable prediction of systemic metastasis, will participate in a panel discussion at the Moffitt Cancer Center’s 9th Annual Business of Biotech Conference in Tampa, FL on Friday, April 17.
Help employers find you! Check out all the jobs and post your resume.
